Tekla Capital Management LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 59 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$1,561,000
+32.6%
233,6120.0%0.06%
+25.0%
Q3 2020$1,177,000
-37.7%
233,6120.0%0.04%
-38.9%
Q2 2020$1,888,000
-58.0%
233,612
-58.7%
0.07%
-64.5%
Q1 2020$4,495,000
-26.9%
566,066
-30.5%
0.20%
-12.9%
Q4 2019$6,150,000
+81.5%
814,5880.0%0.23%
+57.4%
Q3 2019$3,389,000
+44.0%
814,5880.0%0.15%
+54.2%
Q2 2019$2,354,000
+100.7%
814,5880.0%0.10%
+100.0%
Q1 2019$1,173,000
-44.2%
814,5880.0%0.05%
-46.7%
Q4 2018$2,102,000
-41.2%
814,5880.0%0.09%
-30.8%
Q3 2018$3,576,000
-28.4%
814,5880.0%0.13%
-31.2%
Q2 2018$4,993,000
-15.9%
814,5880.0%0.19%
-18.2%
Q1 2018$5,938,000
+16.0%
814,588
+30.5%
0.23%
+17.3%
Q4 2017$5,119,000
-21.9%
624,2880.0%0.20%
-15.8%
Q3 2017$6,555,000
-4.8%
624,2880.0%0.23%
-8.2%
Q2 2017$6,886,000
+14.0%
624,2880.0%0.26%
+9.0%
Q1 2017$6,043,000624,2880.23%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,409,289$24,815,67612.25%
Knoll Capital Management, LLC 600,000$6,180,0006.42%
Vivo Capital, LLC 4,096,428$42,193,2084.62%
GENDELL JEFFREY L 5,615,350$57,838,1053.29%
Tri Locum Partners LP 983,602$10,131,1013.24%
Samsara BioCapital, LLC 967,527$9,965,5283.05%
MPM BioImpact LLC 664,224$6,841,5071.83%
COWEN AND COMPANY, LLC 2,338,302$24,084,5101.68%
RTW INVESTMENTS, LP 7,136,415$73,505,0751.55%
TANG CAPITAL MANAGEMENT LLC 1,000,000$10,300,0001.45%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders